Treatment of Hidradenitis Suppurativa Evaluation Study: The THESEUS Prospective Cohort Study

December 2023 in “ Health Technology Assessment ”

J.R. Ingram, Janine Bates, Rebecca Cannings‐John, Fiona Collier, Angela Gibbons, Ceri Harris, Kerenza Hood, Laura Howells, Rachel Howes, Paul Leighton, Muhammad Riaz, Jeremy Rodrigues, Helen Stanton, Kim S Thomas, Emma Thomas‐Jones

hidradenitis suppurativa laser treatment deroofing conventional surgery oral doxycycline laser therapy doxycycline

TLDR Laser treatment and deroofing are effective options for hidradenitis suppurativa.

The THESEUS prospective cohort study evaluated current management pathways for hidradenitis suppurativa in the UK, involving 151 participants across 10 hospitals. The study found that laser treatment had the highest proportion of participants willing to receive it (69%), followed by deroofing (58%) and conventional surgery (54%). Participant willingness was strongly influenced by clinicians. Fidelity to oral doxycycline was low (52% after 3 months) due to lack of effectiveness and adverse effects. The study established deroofing and laser treatment as viable options in the UK and prioritized these interventions for future randomized controlled trials.

View this study on njl-admin.nihr.ac.uk →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Treatment of Hidradenitis Suppurativa Evaluation Study: The THESEUS Prospective Cohort Study

2 citations, December 2023 in “Health Technology Assessment”

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

research What Causes Hidradenitis Suppurativa?—15 Years After

78 citations, October 2020 in “Experimental Dermatology”

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Similar Research

5 / 680 results

research Hidradenitis Suppurativa: A Comparison of Guidelines

4 citations, January 2018 in “Journal of dermatology & dermatologic surgery”

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

research Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity Assessment and Comorbidities

1 citations, April 2018 in “Revista da Sociedade Portuguesa de Dermatologia e Venereologia”

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

research Hidradenitis Suppurativa: A Practical Review of Possible Medical Treatments Based on Over 350 Hidradenitis Patients

90 citations, April 2013 in “Dermatology online journal”

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

research Comprehensive Overview of Hidradenitis Suppurativa

27 citations, December 2015 in “Mayo Clinic Proceedings”

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

research Annual Convention in the Time of COVID: The 2020 Dermatology Nurses' Association Meeting

1 citations, January 2021 in “Journal of the Dermatology Nurses’ Association”

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.